Controversy: Is Benzalkonium Chloride Necessary in Antiglaucoma Drops?
- Louati Y Clinical Fellow, University of Geneva Hospitals, Glaucoma Sector, Geneva Switzerland.
- Shaarawy T Assistant Physician and Head, Department of Ophthalmology, University Hospitals of Geneva Glaucoma Sector, Geneva, Switzerland.
- 2016-03-22
Published in:
- Journal of current glaucoma practice. - 2012
BAK
Bioavailability
Ocular surface disease and glaucoma
Preservative free glaucoma medication.
Preservatives in glaucoma medication
English
Medical therapy is the first-line option in glaucoma management, with benzalkonium chloride (BAC) being the most frequently used preservative in antiglaucoma medications. Its use is however, known to be associated with deleterious effects on the ocular surface. This review is an attempt to critically evaluate whether BAC really is indispensable for better bioavailability of antiglaucoma drugs and consequently, better IOP control. How to cite this article: Louati Y, Shaarawy T. Controversy: Is Benzalkonium Chloride Necessary in Antiglaucoma Drops? J Current Glau Prac 2012;6(3):104-107.
- Language
-
- English
- Open access status
- bronze
- Identifiers
-
- DOI 10.5005/jp-journals-10008-1115
- PMID 26997764
- Persistent URL
- https://sonar.ch/global/documents/232916
Statistics
Document views: 35
File downloads:
- Full-text: 0